Alpha Teknova (TKNO) Net Income towards Common Stockholders (2020 - 2026)

Alpha Teknova (TKNO) reported Net Income towards Common Stockholders of -$4.6 million for Q1 2026, up 1.94% year-over-year from -$4.5 million in Q1 2025, and up 3.23% quarter-over-quarter from -$4.7 million in Q4 2025.

Alpha Teknova (TKNO) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends

Alpha Teknova (TKNO) has 7 years of Net Income towards Common Stockholders data on file, last reported at -$4.6 million in Q1 2026.

  • Net Income towards Common Stockholders for Q1 2026 came in at -$4.6 million, up 1.94% year-over-year; the trailing twelve-month figure through Mar 2026 was -$17.1 million (up 26.67% YoY), and the FY2025 annual result was -$17.2 million, up 35.66% from the prior year.
  • Net Income towards Common Stockholders rose to -$4.6 million in Q1 2026 per TKNO's latest filing, from -$4.7 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at -$3.6 million in Q2 2025 and troughed at -$22.4 million in Q3 2022.
  • A 5-year average of -$7.8 million and a median of -$6.2 million in 2022 frame the typical range for Net Income towards Common Stockholders.
  • The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders tumbled 739.24% in 2022, then soared 54.77% in 2023.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$13.3 million in 2022, then gained by 19.67% to -$10.7 million in 2023, then soared by 45.86% to -$5.8 million in 2024, then grew by 18.41% to -$4.7 million in 2025, then rose by 3.23% to -$4.6 million in 2026.
  • Business Quant data shows TKNO's Net Income towards Common Stockholders at -$4.6 million in Q1 2026, -$4.7 million in Q4 2025, and -$4.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 366.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 1.99 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -66.53 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -92.12 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 118.42 Mn
10 Alpha Teknova 239.62 Mn 221.84 Mn 3.78 Mn -4.56 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.56 Mn
Dec 31, 2025 -4.71 Mn
Sep 30, 2025 -4.29 Mn
Jun 30, 2025 -3.57 Mn
Mar 31, 2025 -4.65 Mn
Dec 31, 2024 -5.77 Mn
Sep 30, 2024 -7.57 Mn
Jun 30, 2024 -5.36 Mn
Mar 31, 2024 -8.10 Mn
Dec 31, 2023 -10.66 Mn
Sep 30, 2023 -10.15 Mn
Jun 30, 2023 -7.15 Mn
Mar 31, 2023 -8.82 Mn
Dec 31, 2022 -13.27 Mn
Sep 30, 2022 -22.45 Mn
Jun 30, 2022 -6.20 Mn
Mar 31, 2022 -5.50 Mn
Dec 31, 2021 -6.44 Mn
Sep 30, 2021 -3.24 Mn
Jun 30, 2021 -2.25 Mn